SEC Form 4 · accession 0001645627-18-000060
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 18, 2018
Accepted (ET)
Sep 25, 2018 · 12:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 18, 2018 | P | 2,000 | $0.0433 | A | 25,930,798 | D | |
| Common Stock | Sep 18, 2018 | P | 2,000 | $0.045 | A | 25,932,798 | D | |
| Common Stock | Sep 20, 2018 | P | 1,000 | $0.0531 | A | 25,933,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0509 | A | 25,934,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.054 | A | 25,935,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.053 | A | 25,936,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0499 | A | 25,937,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0498 | A | 25,938,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0498 | A | 25,939,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.048 | A | 25,940,798 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0478 | A | 25,941,798 | D | |
| Common Stock | Sep 21, 2018 | P | 100 | $0.0478 | A | 25,941,898 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0478 | A | 25,942,898 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0494 | A | 25,943,898 | D | |
| Common Stock | Sep 21, 2018 | P | 1,000 | $0.0498 | A | 25,944,898 | D | |
| Common Stock | Sep 24, 2018 | P | 1,000 | $0.0496 | A | 25,945,898 | D | |
| Common Stock | Sep 24, 2018 | P | 1,000 | $0.0564 | A | 25,946,898 | D | |
| Common Stock | Sep 24, 2018 | P | 1,000 | $0.0564 | A | 25,947,898 | D | |
| Common Stock | Sep 24, 2018 | P | 1,000 | $0.0568 | A | 25,948,898 | D |
Table II — derivative securities
No Table II lines on this filing.